Population-level impact of HPV vaccination: a global systematic review of ecological, cross-sectional, and cohort studies.
Addisu J Zeleke, Laura Reifferscheid, Umar Yunusa et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review evaluated the population-level impact of HPV vaccination on various HPV-related outcomes across global settings, focusing on low- and middle-income countries. The study found that vaccination programs with at least 70% coverage and early initiation led to significant reductions in HPV infection (58-100%), CIN2+ (30-88%), genital warts (60-90%), and invasive cervical cancer (70-88%).
Key findings
- HPV vaccination reduced HPV infection by 58-100% in high-coverage settings.
- CIN2+ rates declined by 30-88% with effective vaccination programs.
- Genital warts incidence decreased by 60-90% following vaccination.
- Invasive cervical cancer rates dropped by 70-88% in well-implemented programs.
Why it matters
Understanding the effectiveness of HPV vaccination is crucial for public health strategies aimed at reducing cancer incidence. High coverage and early vaccination can significantly lower the burden of HPV-related diseases, particularly in underserved populations.
What to keep in mind
The review noted heterogeneity in study designs, outcome definitions, and follow-up durations across the included studies.